Posts
July 14 2023
PainReform Ltd., a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, announced the pricing of its registered direct offering and concurrent private placement in the amount of $2,700,000. EGS acted as counsel to Maxim Group LLC, the exclusive placement agent for the offering.
July 13 2023
IMAC Holdings, Inc. announced the closing of its Private Placement Offering in the amount of $4,300,000. EG&S acted as counsel to the Placement Agent.
July 12 2023
Tivic Health® Systems, Inc., a health tech company that develops and commercializes bioelectronic medicine, announced the pricing of its previously announced public offering in the amount of $1,800,000. Tivic intends to use the net proceeds of the offering for working capital and general corporate purposes. EGS acted as counsel to Maxim Group LLC, the sole placement agent for the offering.
July 12 2023
C3is, Inc. announced the closing of its Public Offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.
July 12 2023
C3is, Inc. announced the closing of its Public Offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.
July 10 2023
Tivic Health Systems, Inc. announced the closing of its Public Offering in the amount of $1,800,000. EG&S acted as counsel to the Placement Agent.
July 09 2023
RedHill Biopharma Ltd. announced the closing of its Registered Direct offering and Warrant Exercise in the amount of $3,800,000. EG&S acted as counsel to the Placement Agent.
July 09 2023
PainReform Ltd. announced the closing of its Registered Direct offering in the amount of $2,700,000. EG&S acted as counsel to the Placement Agent.